Sign in

CIK 0001590750

  • Large accelerated filer

Viridian Therapeutics, Inc.DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471187261
Phone
+1 617-272-4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-01 CAIN CHRISTOPHER W. Director Grant or award · Stock Option (Right to Buy) +32,341 32,341
2025-07-01 CAIN CHRISTOPHER W. Director Grant or award · Stock Option (Right to Buy) +21,000 21,000
2025-03-10 CAIN CHRISTOPHER W. Director Grant or award · Stock Option (Right to Buy) +42,000 42,000

Page 1 of 1 · 3 trades